dc.contributor.author | Sylvestre, Marie-Pierre | |
dc.contributor.author | Tchouangue Dinkou, Gillis Delmas | |
dc.contributor.author | Armasu, Alexia | |
dc.contributor.author | Pelekanakis, Annie | |
dc.contributor.author | Plourde, Vickie | |
dc.contributor.author | Bélanger, Mathieu | |
dc.contributor.author | Maximova, Katerina | |
dc.contributor.author | Thombs, Brett D. | |
dc.contributor.author | O’Loughlin, Jennifer | |
dc.date.accessioned | 2024-03-20T13:52:30Z | |
dc.date.available | NO_RESTRICTION | fr |
dc.date.available | 2024-03-20T13:52:30Z | |
dc.date.issued | 2022-09-26 | |
dc.identifier.uri | http://hdl.handle.net/1866/32807 | |
dc.publisher | Nature research | fr |
dc.rights | CC BY 4.0 DEED
Attribution 4.0 International | fr |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/deed.fr | fr |
dc.title | Symptoms of depression and anxiety increased marginally from before to during the COVID-19 pandemic among young adults in Canada | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. École de santé publique. Département de médecine sociale et préventive | fr |
dc.identifier.doi | 10.1038/s41598-022-20379-1 | |
dcterms.abstract | We documented changes in depressive and anxiety symptoms from before to during the COVID-19 pandemic among young adults and investigated whether changes differed across participant characteristics. Data were available in an investigation of 1294 grade 7 students recruited in 1999–2000. For this analysis, we used data collected pre-pandemically in 2017–20 (mean (SD) age = 30.6 (1.0)) and during the pandemic in 2020–21 (mean (SD) age = 33.6 (0.6)). 673 participants with data in both cycles were retained for analysis. Symptoms were measured using the Major Depression Inventory (MDI) and the Generalized Anxiety Disorder-7 (GAD-7) scale. Standardized mean differences (SMD) of changes in MDI and GAD-7 values between cycles were calculated across participant characteristics. On average, MDI scores increased by 2.1 (95%CI 1.4, 2.8) points during the pandemic from mean 10.5; GAD-7 scores increased by 1.2 (0.8, 1.5) points from mean 4.7. The SMD was 0.24 (0.14, 0.33) for MDI, and 0.24 (0.13, 0.34) for GAD-7. No differences in MDI change scores were observed across participant characteristics. Differences in GAD-7 change scores were observed by mood/anxiety disorder (SMD − 0.31 (− 0.58, − 0.05)), household income (0.24 (0.02, 48)), living with young children (− 0.56 (− 1.23,− 0.05)), and adherence to public health recommendations 0.58 (0.19, 1.03)). Increases in depressive and anxiety symptoms were observed 10–16 months into the COVID-19 pandemic among adults age 32–36. | fr |
dcterms.isPartOf | urn:ISSN:2045-2322 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | Sylvestre, MP., Tchouangue Dinkou, G.D., Armasu, A. et al. Symptoms of depression and anxiety increased marginally from before to during the COVID-19 pandemic among young adults in Canada. Sci Rep 12, 16033 (2022). https://doi.org/10.1038/s41598-022-20379-1 | fr |
UdeM.VersionRioxx | Version publiée / Version of Record | fr |
oaire.citationTitle | Scientific reports | fr |
oaire.citationVolume | 12 | fr |